These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
921 related articles for article (PubMed ID: 2963831)
1. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. Pannell R; Black J; Gurewich V J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity. Gurewich V; Pannell R Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. Liu JN; Gurewich V J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471 [TBL] [Abstract][Full Text] [Related]
4. Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator. Gurewich V Enzyme; 1988; 40(2-3):97-108. PubMed ID: 2971533 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158). Gurewich V; Pannell R; Broeze RJ; Mao J J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047 [TBL] [Abstract][Full Text] [Related]
6. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. Liu JN; Gurewich V Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004 [TBL] [Abstract][Full Text] [Related]
7. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator. Watahiki Y; Scully MF; Ellis V; Kakkar VV Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259 [TBL] [Abstract][Full Text] [Related]
8. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Pannell R; Gurewich V Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments. Gurewich V; Pannell R Blood; 1987 Mar; 69(3):769-72. PubMed ID: 2949785 [TBL] [Abstract][Full Text] [Related]
10. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946 [TBL] [Abstract][Full Text] [Related]
11. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator. Lijnen HR; Dewerchin M; De Cock F; Collen D Thromb Res; 1990 Feb; 57(3):333-42. PubMed ID: 2107593 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [TBL] [Abstract][Full Text] [Related]
13. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator. Silva MM; Thelwell C; Williams SC; Longstaff C J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122 [TBL] [Abstract][Full Text] [Related]
14. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect. Gurewich V; Pannell R Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707 [No Abstract] [Full Text] [Related]
15. Comparison of affinities of urokinase and tissue plasminogen activator for fibrin clots. Homandberg GA; Wai T Thromb Res; 1989 Aug; 55(4):493-501. PubMed ID: 2510355 [TBL] [Abstract][Full Text] [Related]
16. Clot penetration and fibrin binding of amediplase,a chimeric plasminogen activator (K2 tu-PA). Rijken DC; Barrett-Bergshoeff MM; Jie AF; Criscuoli M; Sakharov DV Thromb Haemost; 2004 Jan; 91(1):52-60. PubMed ID: 14691568 [TBL] [Abstract][Full Text] [Related]
17. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model. Guimarães AH; Rijken DC Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222 [TBL] [Abstract][Full Text] [Related]
18. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Sabovic M; Lijnen HR; Keber D; Collen D Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603 [TBL] [Abstract][Full Text] [Related]
19. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Loza JP; Gurewich V; Johnstone M; Pannell R Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800 [TBL] [Abstract][Full Text] [Related]
20. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]